Lucid Diagnostics Inc. — Director's Dealing 2022

Sep 22, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lucid Diagnostics Inc. (LUCD)
CIK: 0001799011
Period of Report: 2022-09-20

Reporting Person: Lapidus Stanley (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-09-20	Common stock	S	17000	$1.7067	Disposed	152320	Direct
2022-09-20	Common stock	S	16864	$1.70	Disposed	135456	Direct

Footnotes

F1: Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock.

F2: Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which will vest September 20, 2023. Under the plan, unvested shares are subject to forfeiture if the requisite service period is not completed.